The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. From Wikipedia
Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.
